Dave & Dujanovic

FDA approves active ingredient in Mounjaro for weight loss


Listen Later

A new weight loss drug approved by the Food and Drug Administration may make a big impact for those facing obesity. Zepbound (ZEP-bound), includes the same active ingredient as Mounjaro -- a popular weight-loss drug only approved for people with Type 2 diabetes. Dave and Debbie discuss what they know about the drug and how much this new approved medication will cost. 

...more
View all episodesView all episodes
Download on the App Store

Dave & DujanovicBy Debbie Dujanovic and Dave Noriega

  • 4.1
  • 4.1
  • 4.1
  • 4.1
  • 4.1

4.1

40 ratings